LabCorp

267 articles about LabCorp

• Labcorp to Announce Third Quarter Financial Results on October 26, 2023

  9/29/2023

  Labcorp, a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2023 before the market opens on Thursday, October 26, 2023.

• Labcorp to Present Strategy, Business and Financial Outlook at Investor Day

  9/14/2023

  Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, is hosting an Investor Day beginning at 1:00 p.m. ET today in New York City, expected to conclude by approximately 4:00 p.m. ET.

• Xcell Biosciences and Labcorp Achieve Key Data Milestones in Cell and Gene Therapy Collaboration

  8/24/2023

  Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced it has achieved key milestones in its R&D collaboration with Labcorp, a global leader of innovative and comprehensive laboratory services, aimed at driving innovation in the development and validation of cell and gene therapies.

• Labcorp Forges Strategic Partnership with Tufts Medicine, Will Acquire Outreach Laboratory Business

  8/3/2023

  Labcorp announced an agreement with Tufts Medicine, a leading integrated academic health system in Massachusetts, for Labcorp to acquire the Tufts Medicine outreach laboratory business and select operating assets as a first step toward a larger strategic partnership.

• Labcorp to Host Investor Day on September 14, 2023

  7/31/2023

  Labcorp today announced it will host an Investor Day on Thursday, September 14, 2023 , in New York City , beginning at 1:00 p.m. ET and is expected to conclude by approximately 4:00 p.m. ET.

• Labcorp Announces 2023 Second Quarter Results

  7/27/2023

  Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the second quarter ended June 30, 2023, and provided full-year guidance.

• Labcorp OnDemand Offers Menopause Test to Consumers

  7/24/2023

  Labcorp announced today it now offers menopause testing through its Labcorp OnDemand digital health platform.

• GeneCentric Therapeutics Announces Publication of New Results Showing Clinical Benefit of RNA-based Antifolate Predictive Response Signature (AF-PRS) to Guide Lung Cancer Treatment Selection

  7/20/2023

  GeneCentric Therapeutics announced today the publication of initial results from the ongoing Piedmont study using real-world data in lung cancer to develop its novel RNA-based Antifolate Predictive Response Signature (AF-PRS), which is being co-developed as a clinical diagnostic test with Labcorp.

• Labcorp Declares Quarterly Dividend - July 13, 2023

  7/13/2023

  Labcorp  (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock.

• Labcorp Finalizes Strategic Relationship with Jefferson Health

  7/13/2023

  Labcorp (NYSE: LH), a global leader in innovative and comprehensive laboratory services, today announced the completion of the previously announced transaction that establishes a strategic relationship with Jefferson Health ( Jefferson ), the largest health system serving the greater Philadelphia and Southern New Jersey.

• LABCORP AND LEGACY HEALTH AGREE TO COMPREHENSIVE LABORATORY RELATIONSHIP

  7/11/2023

  Labcorp today announced that it has entered into an agreement with Legacy Health to acquire select assets of its outreach laboratory business, including laboratory facilities and equipment.

• Labcorp Completes Spin-off of Fortrea

  7/3/2023

  Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that it has completed the spin-off of Fortrea, the newly formed independent Contract Research Organization providing Phase I-IV clinical trial management, patient access and technology solutions to pharmaceutical and biotechnology organizations around the world.

• Labcorp to Announce Second Quarter Financial Results on July 27, 2023

  6/29/2023

  Labcorp will release its financial results for the second quarter of 2023 before the market opens on Thursday, July 27, 2023.

• Labcorp Awarded Forrester Research 2023 Customer Obsession Leadership Award

  6/14/2023

  Labcorp is pleased to share that its executive vice president and chief marketing officer, Amy Summy, has been awarded the inaugural Forrester Customer Obsession Leadership Award, recognizing senior executives who put customers at the center of everything they do to accelerate business growth, retain customers and enable greater employee engagement.

• Labcorp Announces Pricing of Fortrea $570 Million Notes Offering in Connection With Anticipated Fortrea Spinoff

  6/12/2023

  Labcorp, a leading global life sciences company, announced that Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp, has priced an offering of $570 million of senior secured notes due 2030, in connection with the previously announced spinoff of Fortrea into a separate publicly traded company.

• Labcorp Announces Additional Information in Connection With Its Spin-off of Fortrea

  6/12/2023

  Labcorp, a leading global life sciences company, previously announced the following record and distribution dates for its spin-off of Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp.

• Labcorp Announces Information in Connection with its Spin-off of Fortrea

  6/9/2023

  Labcorp, a leading global life sciences company, announced the following record and distribution dates for the spin-off of Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp.

• Labcorp Announces Launch of Fortrea's Notes Offering in Connection with Anticipated Spinoff

  6/8/2023

  Labcorp, a leading global life sciences company, announced that Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp, has launched an offering of senior secured notes due 2030, subject to market conditions and other customary factors, in connection with the previously announced spinoff of Fortrea into a separate publicly traded company.

• Labcorp Appoints Dr. Paul Rothman to Board of Directors

  6/7/2023

  Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointment of Dr. Paul Rothman to its Board of Directors as an independent member.

• Labcorp's Planned Spin-off, Fortrea, to Host 2023 Investor Day

  6/5/2023

  Labcorp (NYSE: LH), a leading global life sciences company, today announced Fortrea, the new company to be formed by the planned spin-off of Labcorp's Clinical Development and Commercialization Services business, will host its inaugural Investor Day on Tuesday, June 6, 2023, in New York City at 9 a.m. ET.